NASDAQ: NVAX
Novavax Inc Earnings Dates, Reports, Calls

Novavax earnings were -$87.8M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest NVAX earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$9.5M, down 154.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, NVAX reported annual earnings of $440.3M, with -334.8% growth.

NVAX earnings history

Current Revenue
$596.3M
Current Earnings
-$87.8M
Current Profit Margin
-14.7%

NVAX Return on Equity

Current Company
N/A
Current Industry
-143.8%
Current Market
5.2%

NVAX Return on Assets

Current Company
-7.4%
Current Industry
-10.8%
NVAX is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when NVAX announces earnings.

NVAX Return on Capital Employed

Current Company
-9.2%
Current Industry
-6.9%
NVAX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NVAX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
NVAX-$42.13M-$87.84MN/A-$0.54
VIR-$425.53M-$442.72MN/A-$3.12
INBX-$123.57M-$140.06MN/A-$9.04
IOVA-$308.08M-$353.86MN/A-$0.92
AMLX-$149.60M-$150.11MN/A-$1.48

Novavax Earnings Reports & History FAQ

What were Novavax's earnings last quarter?

Novavax (NASDAQ: NVAX) reported Q1 2026 earnings per share (EPS) of -$0.06, up 101.86% year over year. Total NVAX earnings for the quarter were -$9.49 million. In the same quarter last year, Novavax's earnings per share (EPS) was $3.22.

If you're new to stock investing, here's how to buy Novavax stock.

Is Novavax profitable or losing money?

As of the last Novavax earnings report, Novavax is currently losing money. Novavax's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$87.84 million, a 118.35% decrease year over year.

What was NVAX's earnings growth in the past year?

As of Novavax's earnings date in Q2 2026, Novavax's earnings has grown year over year. NVAX earnings in the past year totalled -$87.84 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.